RECRUITING

Tinnitus Patient Preferences Survey

Description

The goal of this survey is to assess several aspects related to patient preferences regarding interventions for alleviating tinnitus through invasive electrical brain stimulation (neuromodulation). This survey covers the acceptance of a surgically-placed brain implant, of its associated risks related to the neurosurgical procedure, usability considerations, and the willingness/ability to pay for such a treatment. Neurosoft Bioelectronics will use the collected patients' feedback and usability preferences data for the development of a novel minimally invasive brain implant aimed at alleviating tinnitus.

Study Overview

Study Details

Study overview

The goal of this survey is to assess several aspects related to patient preferences regarding interventions for alleviating tinnitus through invasive electrical brain stimulation (neuromodulation). This survey covers the acceptance of a surgically-placed brain implant, of its associated risks related to the neurosurgical procedure, usability considerations, and the willingness/ability to pay for such a treatment. Neurosoft Bioelectronics will use the collected patients' feedback and usability preferences data for the development of a novel minimally invasive brain implant aimed at alleviating tinnitus.

Tinnitus Patient Preferences Survey

Tinnitus Patient Preferences Survey

Condition
Tinnitus, Subjective
Intervention / Treatment

-

Contacts and Locations

New York

Neurosoft Bielectronics US Inc., New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Individuals aged 18 or older suffering from subjective tinnitus
  • * Self-reported or healthcare professional-diagnosed chronic (lasting 3 months or longer), subjective, burdensome tinnitus
  • * Individuals under 18 years of age
  • * Healthy volunteers without tinnitus

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Nicolas Gninenko,

Nicolas Gninenko, PhD, PRINCIPAL_INVESTIGATOR, Neurosoft Bioelectronics

Study Record Dates

2025-12-30